BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pharmexa A/S (formerly M&E Biotech A/S) 

6, Kogle Allé

Horsholm    DK-2970  Denmark
Phone: 45-45-16-25-25 Fax: 45-45-16-25-00


SEARCH JOBS




Industry
Biotechnology






 Company News
Pharmexa A/S (PHARMX.CO) and Affitech AS to Combine Operations to Create a New Antibody Therapeutics Company 3/4/2009 7:30:57 AM
Affitech AS Acquires Pharmexa A/S (PHARMX.CO)'s Diabody Technology 10/28/2008 11:31:30 AM
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials 5/13/2008 6:10:13 AM
Pharmexa A/S (PHARMX.CO) Loses European Patent Appeal for Broad Claims to Telomerase-Based Cancer Vaccines 9/4/2007 11:41:45 AM
Pharmexa A/S (PHARMX.CO) and Affitech AS Enter into an Exclusive License Agreement to Promote Diabody Technology 4/3/2007 10:55:29 AM
Cobra BioManufacturing (CBF.L) Announces Manufacturing Agreement With Pharmexa 2/2/2007 1:43:20 PM
Pharmexa A/S (PHARMX.CO) Files The First Phase III Application 2/1/2006 3:03:01 PM
IDM Pharma, Inc. (IDMI) Completes Sale of Non-Core Assets To Pharmexa A/S (PHARMX.CO) For $12 Million Cash 1/3/2006 10:38:24 AM
IDM Pharma, Inc. (IDMI) Enters Agreement To Sell Non-Core Assets To Pharmexa A/S (PHARMX.CO) For $12 Million Cash 11/28/2005 10:56:56 AM
Pharmexa A/S (PHARMX.CO) To Acquire GemVax AS And Launch Rights Issue To Finance Two Large Phase III Trials In Pancreatic Cancer10/19/2005 5:13:15 PM
123